H-LAGIGILTV-OH
Ref. 3D-PP42808
| 1mg | 217.00 € | ||
| 10mg | 253.00 € | ||
| 100mg | 455.00 € |
Product Information
- NH2-Leu-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val-OH
Peptide H-LAGIGILTV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LAGIGILTV-OH include the following: Using molecular dynamics simulations to interrogate T cell receptor non-equilibrium kinetics ZA Rollins , R Faller , SC George - Computational and Structural , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2001037022001350 T Cell Receptor Non-Equilibrium Kinetics ZA Rollins , R Faller , SC George - bioRxiv, 2021 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2021.10.27.466112.abstract Rational design of peptide-based tumor vaccines WS Meng , LH Butterfield - Pharmaceutical research, 2002 - Springerhttps://link.springer.com/article/10.1023/A:1016497818471 Structure based prediction of neoantigen immunogenicity TP Riley, GLJ Keller, AR Smith, LM Davancaze - Frontiers in , 2019 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.02047/full High-throughput functional screening of antigen-specific T cells based on droplet microfluidics at a single-cell level S Wang , Y Liu, Y Li, M Lv, K Gao, Y He, W Wei - Analytical , 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.1c03678 APE-Gen2. 0: Expanding Rapid Class I Peptide-Major Histocompatibility Complex Modeling to Post-Translational Modifications and Noncanonical Peptide R Fasoulis , MM Rigo , G Lizee - Journal of Chemical , 2024 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jcim.3c01667 APE-Gen2. 0: Expanding rapid class I peptide-MHC modeling to post-translational modifications and non-canonical peptide geometries R Fasoulis , MM Rigo , G Lizee , DA Antunes , LE Kavraki - kavrakilab.rice.eduhttps://www.kavrakilab.rice.edu/publications/fasoulis2024-apegen2.pdf Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition OY Borbulevych , FK Insaidoo, TK Baxter - Journal of molecular , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022283607009497 Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/Mart-1 peptide analogue MJ Maeurer , A Necker, RD Salter - journal of cancer, 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.1580 Amino acid substitutions in the melanoma antigen recognized by T cell 1 peptide modulate cytokine responses in melanoma-specific T cells MB Nielsen, AF Kirkin, D Loftus, MH Nissen - Journal of , 2000 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2000/07000/amino_acid_substitutions_in_the_melanoma_antigen.3.aspx MHC-peptide specificity and T-cell epitope mapping: where immunotherapy starts M Provenzano , MC Panelli, S Mocellin, L Bracci - Trends in molecular , 2006 - cell.comhttps://www.cell.com/trends/molecular-medicine/fulltext/S1471-4914(06)00195-X A Superagonist Variant of Peptide MART1/Melan A27-35 Elicits Anti-Melanoma CD8+ T Cells with Enhanced Functional Characteristics: Implication for More L Rivoltini, P Squarcina, DJ Loftus, C Castelli, P Tarsini - Cancer research, 1999 - AACRhttps://aacrjournals.org/cancerres/article-abstract/59/2/301/505586 A novel population of human melanoma-specific CD8 T cells recognizes Melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide L Derre, M Ferber, C Touvrey, E Devevre - The Journal of , 2007 - journals.aai.orghttps://journals.aai.org/jimmunol/article/179/11/7635/81212 A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: implication for molecular anti JS Blanchet, D Valmori, I Dufau, M Ayyoub - The Journal of , 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/10/5852/33825 pDOCK: a new technique for rapid and accurate docking of peptide ligands to Major Histocompatibility Complexes JM Khan, S Ranganathan - Immunome Research, 2010 - Springerhttps://link.springer.com/article/10.1186/1745-7580-6-S1-S2 TCR-induced alteration of primary MHC peptide anchor residue F Madura, PJ Rizkallah , M Legut - European journal of , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201948085 A Novel Population of Human CDT Melanoma-Specific - J Immunol, 2007 - academia.eduhttps://www.academia.edu/download/74576885/7635.pdf Immunological interactions of virus peptides at the antigen presenting MHC I proteins A Rashidian - Bioinformatics, 2018 - utupub.fihttps://www.utupub.fi/bitstream/handle/10024/146525/Rashidian_Azam_Thesis.pdf?sequence=1
Chemical properties
Technical inquiry about: 3D-PP42808 H-LAGIGILTV-OH
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
